USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...

Postoperative penile hypoxia is one potential contributor, Pedersen and co-authors noted. The rationale for LI-SWT to treat ...

A recent research presented at the ENDO 2025 revealed that high blood sugar levels can impact men's sexual health. The ...

There’s a zap for that. Scientists have unsheathed an electriying new treatment for erectile dysfunction that’s reportedly better than popping a little blue pill — radio waves. New research ...

Erectile dysfunction medication could reduce the risk of Alzheimer’s disease, a new study is suggesting, though some experts cast doubt on the link between the two.

Read the full paper here. The post Study finds erectile dysfunction for 1 in 5 men even years after Covid infection appeared first on Boing Boing.

Of 609 men surveyed, 19% continued to have erectile dysfunction after being hospitalized with COVID-19. Nearly half still had ED after two years.

The health study found medications commonly prescribed for erectile dysfunction are associated with significant reductions in deaths, cardiovascular disease, and dementia ...

In the US alone approximately 30 million men are living with erectile dysfunction while an estimated 2 out of every 100 American males is not producing testosterone within a typical healthy range ...

A new head-to-head study of tirzepatide versus semaglutide for weight loss in people living with obesity, but not diabetes, shows that over 72 weeks tirzepatide results in an average weight loss ...

New research highlights that 65.8% of diabetic men suffer from erectile dysfunction. Early detection and better diabetes control are key to reducing this common yet serious condition.

The study found that after 176 weeks, only 10 tirzepatide-treated patients progressed to diabetes, representing a roughly 93% reduction in risk compared to the placebo group. More than 90% of the ...